BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 24909161)

  • 1. The ets transcription factor Fli-1 in development, cancer and disease.
    Li Y; Luo H; Liu T; Zacksenhaus E; Ben-David Y
    Oncogene; 2015 Apr; 34(16):2022-31. PubMed ID: 24909161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current insights into the role of Fli-1 in hematopoiesis and malignant transformation.
    Ben-David Y; Gajendran B; Sample KM; Zacksenhaus E
    Cell Mol Life Sci; 2022 Feb; 79(3):163. PubMed ID: 35412146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Fli-1 in normal cell function and malignant transformation.
    Truong AH; Ben-David Y
    Oncogene; 2000 Dec; 19(55):6482-9. PubMed ID: 11175364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.
    Kinsey M; Smith R; Iyer AK; McCabe ER; Lessnick SL
    Cancer Res; 2009 Dec; 69(23):9047-55. PubMed ID: 19920188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fli1 and Tissue Fibrosis in Various Diseases.
    Mikhailova EV; Romanova IV; Bagrov AY; Agalakova NI
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia.
    Mélet F; Motro B; Rossi DJ; Zhang L; Bernstein A
    Mol Cell Biol; 1996 Jun; 16(6):2708-18. PubMed ID: 8649378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor Fli-1 as a new target for antitumor drug development.
    Li L; Yu J; Cheng S; Peng Z; Luo H
    Int J Biol Macromol; 2022 Jun; 209(Pt A):1155-1168. PubMed ID: 35447268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fli-1 promotes proliferation and upregulates NANOGP8 expression in T-lymphocyte leukemia cells.
    Park SW; Do HJ; Choi W; Kim JH
    Biochimie; 2020 Jan; 168():1-9. PubMed ID: 31626853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ewing's tumours, genetic and cellular aspects].
    Delattre O
    Pathol Biol (Paris); 2008 Jul; 56(5):257-9. PubMed ID: 18485618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.
    Tirado OM; Mateo-Lozano S; Villar J; Dettin LE; Llort A; Gallego S; Ban J; Kovar H; Notario V
    Cancer Res; 2006 Oct; 66(20):9937-47. PubMed ID: 17047056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellites as EWS/FLI response elements in Ewing's sarcoma.
    Gangwal K; Sankar S; Hollenhorst PC; Kinsey M; Haroldsen SC; Shah AA; Boucher KM; Watkins WS; Jorde LB; Graves BJ; Lessnick SL
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10149-54. PubMed ID: 18626011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellites are EWS/FLI response elements: genomic "junk" is EWS/FLI's treasure.
    Gangwal K; Lessnick SL
    Cell Cycle; 2008 Oct; 7(20):3127-32. PubMed ID: 18927503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.
    Riggi N; Suvà ML; Suvà D; Cironi L; Provero P; Tercier S; Joseph JM; Stehle JC; Baumer K; Kindler V; Stamenkovic I
    Cancer Res; 2008 Apr; 68(7):2176-85. PubMed ID: 18381423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.
    Smith R; Owen LA; Trem DJ; Wong JS; Whangbo JS; Golub TR; Lessnick SL
    Cancer Cell; 2006 May; 9(5):405-16. PubMed ID: 16697960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development.
    De Vito C; Riggi N; Suvà ML; Janiszewska M; Horlbeck J; Baumer K; Provero P; Stamenkovic I
    PLoS One; 2011; 6(8):e23592. PubMed ID: 21853155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma.
    Sankar S; Bell R; Stephens B; Zhuo R; Sharma S; Bearss DJ; Lessnick SL
    Oncogene; 2013 Oct; 32(42):5089-100. PubMed ID: 23178492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
    Kinsey M; Smith R; Lessnick SL
    Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma.
    Owen LA; Lessnick SL
    Cell Cycle; 2006 Sep; 5(18):2049-53. PubMed ID: 16969112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1.
    Ben-David Y; Giddens EB; Letwin K; Bernstein A
    Genes Dev; 1991 Jun; 5(6):908-18. PubMed ID: 2044959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature.
    Hancock JD; Lessnick SL
    Cell Cycle; 2008 Jan; 7(2):250-6. PubMed ID: 18256529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.